Comments*

 
  • Evolving Challenges in Promoting Cardiovascular Health

    Evolving Challenges in Promoting Cardiovascular Health

    Organizer: Valentin Fuster (Mount Sinai Medical Center and Centro Nacional de Investigaciones Cardiovasculares)Presented by the New York Academy of Sciences, "la Caixa" Foundation, and the International Center for Scientific Debate (ICSD).
    Reported by Megan Stephan | Posted March 26, 2012

    Overview

    Worldwide, over 17 million people die each year of cardiovascular disease, most as a result of coronary artery disease or stroke. The complex biology and clinical importance of these syndromes form fertile ground for a wide range of research, from basic cellular and molecular studies on pathological mechanisms, to large population studies intended to elucidate evidence-based best clinical practices. In November 2011, distinguished cardiologist Valentin Fuster organized an international conference Evolving Challenges in Promoting Cardiovascular Health, held in Barcelona, Spain, and including researchers from all over the world. The speakers presented work addressing a broad range of challenging basic research questions, including studies intended to measure plaque progression in living organisms, to elucidate the role of high density lipoprotein cholesterol, and to describe the molecular pathology of vascular disease progression. They also described new imaging techniques, new drugs, and new surgical and stem cell transplant techniques for the repair of damaged hearts. Clinical experts described the latest trial findings that will inform future practice in challenging disorders such as atrial fibrillation and refractory angina. Others discussed the current state of the art in preventive care, including control of high blood pressure and lipid disorders. Altogether, the meeting provided a broad, multidisciplinary overview of cardiovascular disease research, and demonstrated how these diverse research approaches intersect with one another in the continuing quest to reduce morbidity and mortality from these ubiquitous disorders.

    Presentations available from:
    Lina Badimon, PhD (Barcelona Cardiovascular Research Center, ICCC–CSIC)
    Josep Brugada Terradellas, MD, PhD, FESC (Hospital Clinic, University of Barcelona)
    Valentin Fuster, MD, PhD (Mount Sinai Medical Center and Centro Nacional de Investigaciones Cardiovasculares)
    Michael A. Gimbrone Jr., MD (Brigham & Women's Hospital and Harvard Medical School)
    Roger J. Hajjar, MD (Mount Sinai School of Medicine)
    Jonathan L. Halperin, MD (Mount Sinai Medical Center)
    Jagat Narula, MD, PhD (Mount Sinai School of Medicine)
    Robert A. Phillips, MD, PhD (University of Massachusetts Medical School)
    Josep Rodés-Cabau, MD (Québec Heart and Lung Institute)
    James H. F. Rudd, MD, PhD, MRCP (University of Cambridge)
    Laurence Sperling, MD (Emory University School of Medicine)
    Miguel Torres, PhD (Centro Nacional de Investigaciones Cardiovasculares)
    Clyde W. Yancy, MD, MSc, FACC, FAHA, MACP (Northwestern University Feinberg School of Medicine)

    Use the tabs above to find a meeting report and multimedia from this event.


    Presented by

    • The New York Academy of Sciences
    • la Caixa Foundation
    • Biocat International Center for Scientific Debate

    Bronze Sponsors

    Esteve

    Ferrer

    Fundación Ramón Areces

    Academy Friends

    Bayer HealthCare

    Laboratorios Servier España

    Siemens, S.A

    This eBriefing is sponsored in part by

    • Philips Healthcare

    Grant Support

    Supported by an independent education grant from Astellas Pharma Global Development and a strategic grant from The Edwards Lifesciences Fund.

    Josiah Macy Jr. Foundation

     

    This eBriefing is part of our Translational Medicine Initiative, sponsored by the Josiah Macy Jr. Foundation and The Mushett Family Foundation.

    EmailPrint